Invitrogen CEO Greg Lucier and Alnylam Pharmaceuticals President and Chief Executive Officer John Maraganore and have been appointed to the board of directors of the Biotechnology Industry Organization. Maraganore and Lucier will serve three-year terms.

Susan Siegel has resigned as president of Affymetrix, the company announced last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.